Inmune Bio Director Ronnie Clark Receives 100,000-Option Award

What Happened
Ronnie Duane Clark, a director of Inmune Bio, Inc. (INMB), received a grant of options covering 100,000 shares on September 15, 2026. The Form 4 reports the award as a derivative acquisition with a reported per-share amount of $0.00 and total reported value of $0. This was an equity award (grant), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-15; Form 4 filed: 2026-09-23 (filing appears later than the typical two-business-day window).
• Grant: options for 100,000 shares reported as acquired at $0.00 (derivative award).
• Vesting: per filing footnote, options vest in 36 equal monthly installments (1/36 per month) beginning one month after grant and fully vest on the three‑year anniversary.
• Plan: Granted under the issuer’s Third Amended and Restated 2021 Stock Incentive Plan (per footnote).
• Shares owned after the transaction: not disclosed in the provided filing.

Context
This is a compensation-related option grant to a director. It is not an immediate purchase or sale of shares and does not indicate an exercise or cashless sale. Such grants are common as part of director compensation; investors should view them as a long-term equity incentive rather than an immediate bullish or bearish trading signal.